Skip to main content

5-(1,4-Dioxa-8-azaspiro[4.5]decan-8-ylmethyl)-3-ethyl-2-methyl-1,5,6,7-tetrahydroindol-4-one

ADVERTISEMENT
Identification
Molecular formula
C17H26N2O3
CAS number
.
IUPAC name
5-(1,4-dioxa-8-azaspiro[4.5]decan-8-ylmethyl)-3-ethyl-2-methyl-1,5,6,7-tetrahydroindol-4-one
State
State

At room temperature, 5-(1,4-dioxa-8-azaspiro[4.5]decan-8-ylmethyl)-3-ethyl-2-methyl-1,5,6,7-tetrahydroindol-4-one is in a solid state.

Melting point (Celsius)
164.00
Melting point (Kelvin)
437.15
Boiling point (Celsius)
463.15
Boiling point (Kelvin)
736.30
General information
Molecular weight
305.40g/mol
Molar mass
305.4030g/mol
Density
1.2350g/cm3
Appearence

This compound typically appears as a white to off-white crystalline powder. It is often synthesized in laboratories for research purposes.

Comment on solubility

Solubility of 5-(1,4-dioxa-8-azaspiro[4.5]decan-8-ylmethyl)-3-ethyl-2-methyl-1,5,6,7-tetrahydroindol-4-one

The solubility of 5-(1,4-dioxa-8-azaspiro[4.5]decan-8-ylmethyl)-3-ethyl-2-methyl-1,5,6,7-tetrahydroindol-4-one can be quite intricate due to its complex molecular structure. Here are some important aspects to consider:

  • Polarity: The presence of functional groups like the -O- (ether) and -N- (amine) can influence the polarity of the molecule, affecting its solubility in various solvents.
  • Solvent Compatibility: This compound may show solubility in polar solvents such as water and alcohols, while being less soluble in non-polar solvents like hexane or benzene.
  • Thermal Effects: The solubility may also change with temperature; typically, increased temperature can enhance solubility for solid compounds.
  • pH Sensitivity: Depending on the pH of the solution, protonation or deprotonation of certain groups may occur, altering the solubility characteristics.

In summary, while the *5-(1,4-dioxa-8-azaspiro[4.5]decan-8-ylmethyl)-3-ethyl-2-methyl-1,5,6,7-tetrahydroindol-4-one* compound could demonstrate solubility in specific polar environments, its overall behavior can be quite nuanced and is dependent on various factors, highlighting the importance of experimental validation to determine precise solubility profiles.

Interesting facts

Interesting Facts about 5-(1,4-Dioxa-8-azaspiro[4.5]decan-8-ylmethyl)-3-ethyl-2-methyl-1,5,6,7-tetrahydroindol-4-one

5-(1,4-Dioxa-8-azaspiro[4.5]decan-8-ylmethyl)-3-ethyl-2-methyl-1,5,6,7-tetrahydroindol-4-one is a fascinating compound with unique features that capture the interest of both chemists and biologists. Here are some key highlights:

  • Complex Structure: This compound features a complex polycyclic structure that includes a spirocyclic moiety, which contributes to its intriguing three-dimensional arrangement and potential biological activity.
  • Potential Therapeutic Uses: Due to its unique molecular structure, compounds like this one may exhibit interesting pharmacological properties, making them potential candidates for drug development in therapeutic areas such as neurology or psychiatry.
  • Synergy of Functional Groups: The presence of both nitrogen and oxygen within its framework can lead to interesting interactions with biological systems, enhancing potential reactivity and selectivity towards specific targets.
  • Synthetic Challenge: The synthesis of such a complex structure typically involves multiple steps, requiring expertise in organic synthesis techniques. This aspect makes such compounds not only intriguing from a theoretical viewpoint but also emphasizes the skills of synthetic chemists.

As one delves deeper into the chemistry of 5-(1,4-dioxa-8-azaspiro[4.5]decan-8-ylmethyl)-3-ethyl-2-methyl-1,5,6,7-tetrahydroindol-4-one, one might reflect on how compounds with complex architectures can reveal a wealth of information regarding their potential uses in nanotechnology, materials science, and medicinal chemistry. The *"molecular complexity"* often corresponds with *"biological richness,"* making such compounds a treasure trove for ongoing research and discovery.

Synonyms
25331-92-4
AL 1612
AL-1612
Indol-4(5H)-one, 5-(1,4-dioxa-8-azaspiro(4.5)dec-8-ylmethyl)-3-ethyl-6,7-dihydro-2-methyl-
803VX4VC4I
3-Ethyl-6,7-dihydro-2-methyl-5-(4,4-ethylenedioxypiperidinomethyl)indole-4(5H)-one
4H-Indol-4-one, 5-(1,4-dioxa-8-azaspiro(4.5)dec-8-ylmethyl)-3-ethyl-1,5,6,7-tetrahydro-2-methyl-
RefChem:110395
5-(1,4-dioxa-8-azaspiro[4.5]decan-8-ylmethyl)-3-ethyl-2-methyl-1,5,6,7-tetrahydroindol-4-one
BRN 1155952
5-((1,4-Dioxa-8-azaspiro[4.5]decan-8-yl)methyl)-3-ethyl-2-methyl-1,5,6,7-tetrahydro-4H-indol-4-one
5-[(1,4-Dioxa-8-azaspiro[4.5]decan-8-yl)methyl]-3-ethyl-2-methyl-1,5,6,7-tetrahydro-4H-indol-4-one
3-Ethyl-5-(4,4-ethylenedioxypiperidino-1-methyl)-6,7-dihydro-2-methylindol-4(5H)-one
UNII-803VX4VC4I
orb1698601
DTXSID20948172
AKOS040750273
4H-Indol-4-one, 1,5,6,7-tetrahydro-5-(1,4-dioxa-8-azaspiro(4.5)dec-8-ylmethyl)-3-ethyl-2-methyl-
Q27269107
3-ETHYL-6,7-DIHYDRO-2-METHYL-5-(4,4-ETHYLENEDIOXYPIPERIDINOMETHYL)INDOLE-4(5H)ONE